Intellectual Property

Paclitaxel, Taxol

Other KEI comments on NIH licenses are found here:

Perhaps start with these two:

  • Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991. Published in 1992, by G.P.O., Serial No. 102-35.

WTO LDC patent waiver

May 11, 2015 consolidated text of Intellectual Property Chapter for TPP

August 4, 2015. Press Release for initial release of patent and enforcement provisions: Knowledge Ecology International Leaks TPP Text on Intellectual Property, (PDF)

Compulsory licenses

I'll add more content to this page later. Right now, here are some examples of US statutes that provide for the compulsory licenses of patented inventions.

Statutes regarding compulsory licenses on patents, in the United States

28 USC 1498 - Patent and copyright cases
28 USC 1498(a).

The USTR Special 301 Reports, 1989 to 2014

The USTR's Special 301 Report has been issued every year beginning in 1989. The Executive Summary of the 2009 report says:

CPTech's 2003 reports for the RSA Competition Commission, in Hazel Tau et al.v GSK, Boehringer, et al

On August 13, 2014, the Republic of South Africa (RSA) Competition Commission (CC) released the redacted versions of the reports provided to the CC by CPTech in 2003 in the TAC competition case involving GSK and Boehringer Ingelheim. A complete set of the documents is available here, and links to individual documents are listed below.


Some key events in the early development of the proposal for a Pan African Intellectual Property Organization
Joelle Dountio
10 February 2013

US Congress

Hearings on intellectual property rights, 112th Congress

House of Representatives

Syndicate content